[Scleroderma: Pathogenesis, pathophysiology, and therapy].
Imai
Hirokazu
H
Division of Nephrology and Rheumatology, Department of Internal Medicine, Aichi Medical University School of Medicine.
Suzuki
Keisuke
K
D058186:Acute Kidney Injury / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D011464:Epoprostenol / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D011379:Prognosis; D011458:Prostaglandins E / Q000008:administration & dosage; D012595:Scleroderma, Systemic / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D014182:Transplantation, Autologous
D007166:Immunosuppressive Agents; D011458:Prostaglandins E; D011464:Epoprostenol